Xanthopoulos, A.; Katsiadas, N.; Skoularigkis, S.; Magouliotis, D.E.; Skopeliti, N.; Patsilinakos, S.; Briasoulis, A.; Triposkiadis, F.; Skoularigis, J.
Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure. Life 2023, 13, 1778.
https://doi.org/10.3390/life13081778
AMA Style
Xanthopoulos A, Katsiadas N, Skoularigkis S, Magouliotis DE, Skopeliti N, Patsilinakos S, Briasoulis A, Triposkiadis F, Skoularigis J.
Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure. Life. 2023; 13(8):1778.
https://doi.org/10.3390/life13081778
Chicago/Turabian Style
Xanthopoulos, Andrew, Nikolaos Katsiadas, Spyridon Skoularigkis, Dimitrios E. Magouliotis, Niki Skopeliti, Sotirios Patsilinakos, Alexandros Briasoulis, Filippos Triposkiadis, and John Skoularigis.
2023. "Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure" Life 13, no. 8: 1778.
https://doi.org/10.3390/life13081778
APA Style
Xanthopoulos, A., Katsiadas, N., Skoularigkis, S., Magouliotis, D. E., Skopeliti, N., Patsilinakos, S., Briasoulis, A., Triposkiadis, F., & Skoularigis, J.
(2023). Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure. Life, 13(8), 1778.
https://doi.org/10.3390/life13081778
